Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 6 of 6 drugs
No. | DrugBank | Drug (Description in trials) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Dalfampridine | [7] 4-Aminopyridine 4-Aminopyridine; 4-AP; AMPYRA; Dalfampridine; FAMPRIDINA; FAMPRIDINE; FAMPYRA | [1] Dalfampridine
Dalfampridine
💬1. Dalfampridine
| [4] KCNA4 KCNA4,KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia ... | [5] 3 3, 4, 6, 13, 14 💬
| ||||||||||||||||||||||||||||||||||
2 | Dexmedetomidine | [4] Dexdor Dexdor; DEXMEDETOMIDINA; Dexmedetomidine; DEXMEDETOMIDINE HYDROCHLORIDE | [1] Dexmedetomidine
Dexmedetomidine
💬2. Dexmedetomidine
| [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [14] 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬2. Dexmedetomidine
| ||||||||||||||||||||||||||||||||||
3 | Esketamine | [3] ESKETAMINE ESKETAMINE; KETAMINE; S-ketamine | [1] Esketamine
Esketamine
💬3. Esketamine
| [5] GRIN1 GRIN1,GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 3. Esketamine | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium si ... | [3] 2 2, 4, 70 💬
| ||||||||||||||||||||||||||||||||||
4 | Ketamine | [2] Ketamine Ketamine; NMDA | [1] Ketamine
Ketamine
💬4. Ketamine
| [5] GRIN1 GRIN1,GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 4. Ketamine | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium si ... | [8] 2 2, 4, 6, 13, 70, 113, 156, 215 💬
| ||||||||||||||||||||||||||||||||||
5 | Levetiracetam | [2] KEPPRA KEPPRA; Levetiracetam | [1] Levetiracetam
Levetiracetam
💬5. Levetiracetam
| [1] SV2A SV2A 💬5. Levetiracetam
| [1] ECM-receptor interaction ECM-receptor interaction 💬 | [5] 2 2, 4, 6, 13, 307 💬
| ||||||||||||||||||||||||||||||||||
6 | Pyrimethamine | [2] Daraprim Daraprim; PYRIMETHAMINE | [1] Pyrimethamine
Pyrimethamine
💬6. Pyrimethamine
| - | - | [12] 2 2, 4, 6, 13, 19, 46, 51, 63, 65, 96, 97, 265 💬6. Pyrimethamine
|